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Biological Variation and Reference Change Values of
TSH, Free T3, and Free T4 Levels in Serum of Healthy
Turkish Individuals
Aim: Thyrotropin (TSH), thyroxine (T4) and triiodothyronine (T3) levels in serum are important for diagnosis
of thyroid dysfunction. Thyroid function tests have considerable biological variations. Evaluation of the
components of biological variation is essential to assess the usefulness of reference values and to evaluate
significance of changes in serial results from an individual. Published estimates may show disagreement about
the values of biological variations. Not many studies exist at present that evaluate the reference change values
(RCV) of these parameters. The aim of this study was to determine the biological variations of TSH, free T3,
and free T4 and to calculate their RCV values in serum of healthy individuals in our population.
Materials and Methods: The study group included 46 healthy volunteer subjects (mean age 33.5 ± 9 years).
During six consecutive weeks, four blood samples were obtained for each subject at two-week intervals. Serum
TSH, free T3, and free T4 levels were measured by an immunoluminometric assay on a random-access
analyzer.
Results: The intra-individual/inter-individual biological variations (defined in terms of percent coefficient of
variation, CV) for serum TSH, fT3, and fT4 were 37.21/37.6%, 22.32/2.43%, and 13.26/7.47%
respectively. The RCVs for TSH, fT3, and fT4 were 104.0%, 63.1%, and 38.8%, respectively (P < 0.05).
Conclusions: TSH, fT3, and fT4 showed a significant intra-individual biological variation. The utility of
population-based reference intervals for TSH would be of limited use. During evaluation, especially when
monitoring thyroid functions, the estimates of biological variations and the RCV values should be considered.
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Sa¤l›kl› Türk Bireylerde TSH, Serbest T3, Serbest T4 Düzeylerinin Biyolojik
Varyasyonu ve Referans De¤iﬂim De¤erleri
Amaç: Serum TSH, T4, T3 düzeyleri, tiroid fonksiyon bozukluklar›n›n tan›s›nda önemli bir yere sahiptir. Tiroid
fonksiyon testleri dikkate de¤er düzeyde biyolojik varyasyona sahiptir. Biyolojik varyasyonun bileﬂenlerinin
incelenmesi, topluma dayal› referans aral›¤›n kullan›labilirli¤inin de¤erlendirilebilmesi için gereklidir. Çeﬂitli
yay›nlarda, biyolojik varyasyon de¤erleri farkl› bildirilebilmektedir. Biz bu çal›ﬂmada; TSH, T4, T3 düzeyleri için
biyolojik varyasyon ve referans de¤iﬂim de¤erlerini araﬂt›rmay› amaçlad›k.
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Yöntem ve Gereç: Gönüllü, 46 sa¤l›kl› birey (yaﬂ ortalamas› 33.5 ± 9 y›l) çal›ﬂmaya al›nd›. Alt› hafta boyunca,
ikiﬂer hafta aral›klarla, her bir bireyden toplamda dörder tane serum örne¤i topland›. Serum TSH, serbest T3,
serbest T4 düzeyleri immünoluminometrik test ile bir otoanalizörde ölçüldü.
Bulgular: TSH, serbest T3, serbest T4 için birey-içi / bireyler-aras› biyolojik varyasyonlar s›ras›yla %
37.21/37.6, % 22.32/2.43, % 13.26/7.47 idi. Referans de¤iﬂim de¤erleri s›ras›yla % 104.0, % 63.1, %
38.8 bulundu (P < 0.05).
Sonuç: TSH, serbest T3, serbest T4 anlaml› düzeyde birey-içi biyolojik varyasyon göstermektedir. TSH için
topluma dayal› referans aral›¤›n kullan›labilirli¤i s›n›rl› de¤ere sahiptir. Tiroid fonksiyolar›n›n takibi, incelenmesi
durumunda biyolojik varyasyonun dikkate al›nmas› gerekti¤i unutulmamal›d›r.
Anahtar Sözcükler: Biyolojik varyasyon, TSH, serbest T3, serbest T4

drgonulerden@gmail.com

153

ERDEN, G et al.

Biological Variations of TSH, fT3, fT4

Turk J Med Sci

Introduction

Materials and Methods

Thyroid dysfunction is common (1). Symptoms and
signs of hyperthyroidism and hypothyroidism are often
non-specific and vague if present (2) and measurement of
thyrotropin (TSH), thyroxine (T4) and triiodothyronine
(T3) in serum is important for diagnosis of overt and
subclinical thyroid dysfunction (3).

The study lasted from 2 March 2006 until 14 April
2006 (6 consecutive weeks). Forty-six healthy subjects
(mean age 33.5 ± 9 years) participated in the study; 23
males and 23 females (pre-menopausal). They had an
average body mass index of 24.8 ± 3.86 kg/m2, range
18.5-33.6. All subjects were volunteers and were
selected from among laboratory personnel and their
friends. All subjects provided written informed consent in
accordance with the ethical standards of the local ethical
committee. Inclusion criteria were no chronic disease
(diabetes mellitus, hypertension, thyroid disease,
coronary artery disease, anemia, etc.) and a stable settled
lifestyle. Exclusion criteria for subjects were: major
medical illnesses (e.g. endocrine or autoimmune
disorders); use of any medication, including oral
contraceptive drugs; a past history of psychiatric or
personality disorders; heavy tobacco or alcohol use; and
substance use or abuse. None of the women was
pregnant during the study span.

A test result in an individual is usually compared to a
laboratory reference range. Such a reference range is
often defined by a probability distribution including 95%
of test results in healthy individuals in a population.
Hence, the variation in the population determines the
width of the population-based reference range (4).
Large variations exist in TSH and thyroid hormones in
serum (4). The components of variation include preanalytical, analytical and biological variation. Biological
variation is divided into intra(within)-(CVI) and
inter(between)-(CVG) individual variation (5). The former
is characterized by rhythmic aberrations of multiple
frequencies (6) and the latter is caused by different setpoints around which each individual varies (7).

Some studies on the biological variations of free
(f)T3, fT4 and TSH concentrations in serum have been
reported. These have been done on different numbers of
individuals, over different time periods, with different
assay methods and in different countries. The published
estimates may be discrepant regarding the values of
biological variations, and not many studies have evaluated
the RCV of these parameters.

We determined biological variations by blood sampling
on 4 occasions at 2-week intervals (5,10). Blood
collections were performed in standardized conditions in
order to minimize sources of pre-analytical variation.
Venipuncture was performed after an overnight fast,
between 8-10 a.m. in the antecubital vein of the subjects.
All blood samples were collected from seated subjects by
three experienced investigators (3 medical doctors) using
conventional venipuncture with minimal stasis. Each
subject always had blood sampling carried out by the
same investigator. The samples were allowed to clot
before separation by centrifugation at 3000g for 15 min.
All serum samples were stored frozen at -20ºC until
testing at the end of the collection period as
recommended or as described in the literature. Each
sample from one individual was assayed in duplicate and
after removing outliers, the average value of the
individual’s duplicate measurements was used for
statistical procedures. Outliers were determined as those
exceeding ± 3SD (11). After exclusion of any outliers, 35
subjects for TSH, 42 subjects for fT3, and 41 subjects for
fT4 were included in final statistical analysis.

In this study, we evaluated the biological variations
and RCVs of TSH, fT3, and fT4 in serum of healthy
individuals in our population.

All assays for each parameter were performed by the
same analyst. Using this standardized procedure, preanalytical variation was considered negligible.

Data on the biological variations of analyte
concentrations or other quantities have important uses in
clinical chemistry, including judging the usefulness of
conventional population-based reference ranges (8),
assessing the true significance of changes in results
obtained for serial specimens from a single patient , and
determining the standards of performance, or analytical
goals, required to facilitate optimal patient care (9). Thus,
for serial results to be significantly different, the
difference in numerical results must be greater than the
combined variation inherent in the two results. This value
is traditionally referred to as the critical difference but is
better called the reference change value (RCV) (5).
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We measured serum TSH, fT3, and fT4 levels by an
immunoluminometric assay on a random-access analyzer
(Architect i2000; Abbott Diagnostics Division). Biological
principle of the procedure was chemiluminescent
microparticle immunoassay. The reference intervals used
in our laboratory for TSH, fT3, and fT4, respectively, are
(0.35-4.94 uIU/ml), (1.71-3.71 pg/ml), and (0.7-1.48
ng/dl).
The within-run (intra-assay) analytical variation was
minimized by assaying all of the samples with the same
lots of reagent on the same day. Furthermore, all samples
from a subject were analyzed in random order in the
same assay to eliminate inter-assay variation. We
determined the coefficients of analytical variation (CVA)
from analyses of several serum control pools running
concurrently with assays of the study group. For each
assay, we used two lyophilized pools obtained
commercially. For each pool, we determined the mean
and standard deviation and then calculated CVA with the
following formula: CVA= (SD/mean) ×100. Because the
CVA values for different quality control sera were similar,
we used the average CVA for the control serums (10-15).
Statistical Data
Biological variation was defined as the mean CV. The
total variation, the CV, expressed in terms of percent CV,
was calculated for each individual using the formula:
percent coefficient of variation = (standard
deviation/mean) ×100.
For each subject, we calculated the mean, SD and
variation of the TSH, fT3, and fT4 values for the four
visits by means of a commercially available statistics
program (SPSS 10 and Microsoft Excel). From these
data, the mean and SD for the entire population were
calculated. The total variation in the measurements for
four specimens from one subject is composed of the
biological variation and the analytical variation. The intraindividual biological variations were calculated by means
of the following formula (5,14):
2
2
2
(CVI) =(Total CV) - (Analytical CV)

One-half of the mean CVI is proposed as the quality
specification for imprecision, i.e., CVA < 0.5 CVI.
2
G

The inter-individual variance (SD ) reflects the
difference between the means of the individuals and
excludes intra-individual biological and analytical
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2
2
variation. To determine SDG , the total variance (SDT ) was
calculated by use of all of the individuals’ data sets and
transformed to relative SD (CVT) by use of all of the
overall means. The inter-individual biological variation
(CVG) was calculated by means of the following formula
described by Fraser and Harris:

CVG = (CVT2 – CVI2 – CVA2 )1/2
From the data generated, RCV was calculated using
this formula:
RCV = 2

1/2

* Z * (CVA2 + CVI2)1/2

The number 2 in the formula is a constant for two
measurements. RCV should be adjusted to local
laboratory standards. In usual practice, we want to know
about change in general and thus apply bidirectional Zscores. 95.5% probability is conventionally regarded as
significant. In consequence, generally 1.96 is the
appropriate Z-score to use. The RCV provides the limit
for a change attributable to random variation with
probability specified by the Z value (5,14).

Results
Parametric means and absolute ranges for serum fT3,
fT4 and TSH measurements for the subjects are shown in
Figures 1, 2, 3.
Evaluation of means of serial serum measurements of
individuals (mean, median, SD, minimum and maximum)
are given in Table 1.
Results of calculations of TSH, fT3, and fT4 for CVA,
CVI, CVG, RCV, and index of individuality (CVI / CVG) are
given in Table 2.

4
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Figure 1. Parametric means and absolute ranges for serum fT3.
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Figure 2. Parametric means and absolute ranges for serum fT4.
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Figure 3. Parametric means and absolute ranges for serum TSH.

Table 1. Evaluation of means of serial serum measurements of individuals.
Mean

SD

Median

Min-Max

fT3 (pg/ml)

2.66

0.310

2.69

1.99-3.17

fT4 (ng/dl)

0.91

0.092

0.93

0.75-1.09

TSH (uIU/ml)

1.04

0.398

0.99

0.36-1.91

Table 2. Calculated components of variance.
CVA %

CVI %

CVG %

RCV %

fT3

4.60

22.32

2.43

63.17

9.1

fT4

4.57

13.26

7.47

38.87

1.77

TSH

4.91

37.21

37.60

104.04

0.98

Discussion
The major findings of this study are that (i) the serum
concentrations of TSH, fT3, and fT4 show a significant
intra-individual biological variation, (ii) the intraindividual variability of these parameters is not much
lower than the inter-individual variability, and (iii) RCV,
the critical difference for a change between two
consecutive concentrations, is considerably high for all.
The ratio of intra-(CVI) to inter-(CVG) individual
variation, also known as the index of individuality (Iindex), is important in determining the use of
population–based reference intervals in detecting changes
in disease status of individuals (4,15). When the I-index is
low (<0.6), the individual results stay within a narrow
range compared with the population reference interval.
Hence, a low index suggests the utility of evaluating serial
changes in analyte values in an individual, and populationbased reference intervals would be of limited use. A high
index (>1.4) suggests that the reference interval is
156

CVI / CVG

appropriate (16). It is generally pronounced that this
ratio is low for serum TSH, T3, and T4, indicating that
laboratory reference ranges are relatively insensitive to
aberrations from normality in the individual. However,
the results of the present study for fT3 and fT4 are not
similar to published estimates (2,13). I-indexes for fT3
and fT4, by our estimation, are higher than 1.4.
The present study found a similar ratio (I-index=0.98)
for serum TSH when compared with the ratios reported
by Ricos et al. (19.3/19.7 = I-index = 0.97) (17),
Andersen et al. (I-index = 0.49) (18), Maes et al.
(29.3/48.4 = I-index = 0.60) (6), and Browning et al.
(16.2/31.7 = I-index = 0.60) (13). The ratio of intra- to
inter-individual variation was low for serum TSH in all
studies (4,13,18). This implies that some individuals with
TSH within the population-based reference range have a
TSH outside the individual reference range. This is
illustrated in cross-sectional population studies in which
participants with serum TSH close to the outer limits of
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the laboratory reference range have a higher frequency of
thyroid abnormalities (4). As found by others, for TSH,
population-based reference range is an insensitive
measure in the large majority of individuals.
The optimal level of thyroid hormones and TSH in
serum to attain physical and mental well-being has not
been established, but the trend these years is to narrow
the range of serum TSH regarded as optimal. Detrimental
effects on the cardiovascular system have been reported
for suppressed and particularly elevated serum levels of
TSH, and follow–up studies have shown an increase in
risk of development of overt thyroid dysfunction in
subjects with high normal serum TSH levels (19,20).
In practice, population-based reference ranges for
TSH are necessary, but it is important to recognize their
limitations for use in individuals. Serum TSH responds
with amplification to minor alterations in T4 and T3
(21,22). The importance of TSH in diagnosis and
monitoring of thyroid dysfunction is indicated.
Furthermore, it implies that subclinical thyroid disease
may be defined in purely biochemical terms. Under clinical
circumstances such as pregnancy, where normal thyroid
function is of importance for fetal brain development,
subclinical thyroid disease should be treated. Even TSH
within the reference range may be associated with slightly
abnormal thyroid function in an individual. The clinical
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importance of such small abnormalities in thyroid
function in small children and pregnant women for brain
development remains to be elucidated (4).
Knowledge of the details of predictable biological
cyclical rhythms is required for correct clinical
interpretation of laboratory data (23). Inherent biological
variation affects all quantities examined in laboratory
medicine and must be taken into account in both the
generation and the application of reference values (23).
In the present study, CVI and CVG values for TSH and
fT3 were not comparable with some of the previous
reports (see Table 3). Our values were higher than some
of the others. This may be explained by the season
(March – April) in which our study was undertaken. It is
reported that TSH and fT3 show significant yearly
variations, characterized by annual, biannual and
trimonthly rhythms (6).
There is a need for validation of the results of this
study with further researches.
In conclusion, we report the importance of biological
variation of serum TSH when evaluating the levels of TSH
and thyroid hormones. Quality specifications in laboratory
medicine are best based on calculations involving
biological variation.

Table 3. Published data on biological variations of fT3, fT4 and TSH.
fT3

fT4

TSH

CVI %

CVG %

CVI %

CVG %

CVI %

CVG %

Present study

22.3

2.4

13.2

7.4

37.2

37.6

Reference (14)

7.9

-

7.6

12.2

19.7

27.2

Reference (6)

-

-

7.1

9.1

29.3

48.4
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